Antitumor effect of FGFR inhibitors on a novel cholangiocarcinoma patient derived xenograft mouse model endogenously expressing an FGFR2-CCDC6 fusion protein

Yu Wang, Xiwei Ding, Shaoqing Wang, Catherine D. Moser, Hassan M. Shaleh, Essa A. Mohamed, Roongruedee Chaiteerakij, Loretta K. Allotey, Gang Chen, Katsuyuki Miyabe, Melissa S. McNulty, Albert Ndzengue, Emily G. Barr Fritcher, Ryan A. Knudson, Patricia T. Greipp, Karl J. Clark, Michael S. Torbenson, Benjamin R. Kipp, Jie Zhou, Michael T. BarrettMichael P. Gustafson, Steven R. Alberts, Mitesh J. Borad, Lewis R. Roberts

Research output: Contribution to journalArticlepeer-review

39 Scopus citations

Fingerprint Dive into the research topics of 'Antitumor effect of FGFR inhibitors on a novel cholangiocarcinoma patient derived xenograft mouse model endogenously expressing an FGFR2-CCDC6 fusion protein'. Together they form a unique fingerprint.

Medicine & Life Sciences